Pipeline playbook

How to build new logo pipeline for cleanroom and facility qualification

A biotech company announces a new manufacturing facility with a press release, a building permit and a state incentive award, usually eighteen months before it needs a qualification team and about twelve months before it realizes that. Every one of those documents is public. This is how to be the firm on the schedule when the schedule is written.

Who actually signs

On a facility project at a biotech, a cell and gene therapy company, a medical device maker or a contract manufacturer, the signer is the VP of operations, the head of manufacturing, or the head of quality. The project director owns the schedule and is the champion. The architecture and engineering firm owns the building and is, quietly, a competitor for the commissioning scope and an ally for the qualification scope, which they usually do not want.

At companies building their first commercial facility there is often no validation function at all. There is a quality director who has run a clinical supply operation, a project director from the engineering firm's side, and a board timeline tied to a clinical milestone that does not care about the qualification schedule.

The one sentence version

Your buyer is a head of manufacturing with a building under construction, a licensure inspection on the calendar, and a plan that has commissioning on it and qualification nowhere.

The triggers, and where each one is visible

  • Facility announcements. New manufacturing sites, expansions and capacity additions are press releases with square footage, location and a target date. The reshoring wave of the last two years has produced a steady stream of them, from large pharma down to the suppliers and contract manufacturers that follow them.
  • Building permits and state incentive awards. Both are public records. A permit for a life sciences fit out in a known cluster is a project, and an incentive award names the company, the investment and the jobs, which means the timeline.
  • Funding at manufacturing stage. A biotech raising to move into commercial manufacturing, or a cell and gene therapy company raising after a pivotal readout, is about to build or lease a facility. Form D filings and the usual databases surface the rounds, and the press release says what the money is for.
  • Inspection findings. Agency inspection observations and warning letters that cite equipment qualification, facility controls or environmental monitoring are public, with a lag, and each one comes with a response commitment and a date.
  • Validation and facilities job posts. A biotech advertising for its first validation engineer, a facilities manager or a CQV lead has a facility on the way and no one to qualify it. The req is usually open for months, which is the engagement.
  • Clinical progress that implies commercial supply. A pivotal trial start, a breakthrough designation or a filing announcement at a company with no commercial facility is a company that will need one, and the timeline is the clinical timeline.

The facility announcement is the trigger to build on. It arrives early, it names the company and the location, and it starts a clock the company has not yet drawn a qualification schedule against.

Qualify in sixty seconds

  • Is the facility regulated? A GMP manufacturing or fill finish site is in scope. A research lab or a pilot facility that will not be inspected is not, however clean the rooms are.
  • Where is the project in its lifecycle? Design is ideal, construction is good, mechanical completion is urgent, and a licensure inspection date on the calendar is an emergency.
  • Is there a validation function in house? Team page and job posts. A company with a qualification group buys overflow. A company with none buys the program.
  • What is the inspection driver? A pre approval inspection, a pre licence inspection, or a response to findings. Each one names a date and a scope.

The angle that gets replies

Lead with the handoff between commissioning and qualification, because that is the gap the engineering firm does not own and the owner has not noticed. The press release said the facility would be operational by a date. The angle is what operational means to an inspector.

Three openers you can adapt

  • On a facility announcement"Congratulations on the new site. The date in the announcement is usually the construction date, and the inspector's date is after qualification, which on a facility that size runs several months if it is planned in design and longer if it is planned at mechanical completion. The decision that sets the difference is whether commissioning documentation is written to be leveraged into qualification. One page on how that is set up, attached."
  • On an inspection finding citing equipment qualification"Saw the observation citing the autoclave qualification. The response commitment usually promises a requalification with a date, and the part that catches teams is that the requalification has to be done to the current approach, not the one the original was done to. A contract team can hold the date without pulling your quality staff off the floor. Happy to scope it against the commitment."
  • On a cell and gene therapy raise for commercial manufacturing"Congratulations on the round and the manufacturing plan. Companies at this point usually choose between building and leasing, and either way the qualification scope is set by the contamination control strategy, which has to exist before the room classifications are final. Most first facilities write it after. Two paragraphs on the order we would run it in, attached to nothing."

Each one names a decision the owner is about to make or has just made, and the consequence for the inspection date. That is what a project director forwards to the VP.

What not to send

  • "Validation services" as the opener. Every firm in the space has that page and the reader has received it from all of them.
  • "We do IQ, OQ and PQ." So does everyone. Naming the phases is a menu, not a finding.
  • "Guaranteed to pass inspection." Nobody who has sat through an inspection believes it, and the phrase suggests you have not.
  • Engineering firm vocabulary. If the note reads like it came from the construction side, the owner will forward it to the construction side, where it will die.

The objection you will hit

Our engineering firm handles commissioning. Yes, and commissioning proves the building works. Qualification proves the facility is fit for its regulated use, to a standard an inspector will read, and the engineering firm's scope usually ends at the first and its documents are usually not written to support the second. Ask who owns the qualification plan. The pause is the engagement.

The second is our quality team will do it. A quality team of two, already running clinical supply, cannot execute the qualification of a new facility and prepare for the licensure inspection at the same time. That is several full time people for most of a year. Contract qualification is how first facilities get done, and the quality director usually knows it.

The third is we will hire validation engineers. The market for them is a contract market, the hire takes months, and the facility does not wait. A contract team now and a hire later is the sequence most first facilities follow, whether they planned to or not.

Deal shape

  • Qualification master plan and strategy: commonly $20K to $60K, best sold during design and the engagement that sets the scope of everything after it.
  • Full commissioning, qualification and validation program for a facility: $300K to several million, scaling with the facility, usually structured as a staffed team over the construction and startup period.
  • Cleanroom classification and qualification, including airflow, particle and recovery studies: $30K to $150K.
  • Equipment qualification: $5K to $30K per unit, and the volume line on most projects.
  • Inspection readiness and mock inspection: $50K to $200K.
  • Requalification and response support after findings: $30K to $150K, closing quickly against a commitment date.
  • Signer: VP Operations, head of manufacturing or head of quality. Cycle: one to four months, tied to the construction schedule, and days against a commitment date.

The master plan is the funnel. It is priced so the head of manufacturing signs it without a capital request, and it produces the schedule and the resource plan, which is the program.

A cadence you can actually run

  • Weekly, pull facility announcements, incentive awards and life sciences building permits in the clusters you serve.
  • Weekly, pull funding at manufacturing stage and clinical milestones at companies with no commercial facility.
  • Monthly, pull inspection findings citing facility and equipment, and validation and facilities job posts.
  • Qualify against the four checks, with the lifecycle position first. One message per account, naming the decision. Ten to fifteen accounts a week is a full program, because the universe is projects, not companies.
  • Three touches over three weeks, then stop. The next milestone on the project is a fresh reason to write.

The facility is announced a year before it needs you. The firms that grow are the ones on the schedule at the groundbreaking, not the ones called at mechanical completion.

The sending mechanics most people get wrong

Everything above is about who and what. This is about how, and it is where most outbound in this niche quietly dies. Seven rules. None of them are optional.

1.Three to five sentences. That is the whole email.

Your reader is on a phone between meetings. One observable fact about their company, one consequence they have not thought about, one specific thing you would do. Anything past five sentences is a memo, and memos get archived unread.

2.Lead with a technical differentiator that turns into a number.

The messages that work best name something concrete you do differently and translate it into time or money saved. In this niche the differentiator is leverage. A firm that writes commissioning documentation to be leveraged directly into qualification, and can say how many months that took off the last three facility startups, has the number the project director is looking for. The second is inspection outcome: state how many facilities you qualified that passed their licensure inspection without a facility or equipment observation.

Most services firms do not have a technical differentiator, and pretending to have one reads as exactly that. The substitute is a verticalized case study: a company like theirs, what you did, what happened, in one sentence. For this niche the line is: a first commercial cell therapy facility, master plan written during design, commissioning leveraged into qualification, qualification complete four months after mechanical completion, licensure inspection passed with no facility observations, no in house validation hires until after licensure. The month count and the clean inspection are what the reader will check.

3.Ten to twenty emails a day per mailbox. Not a hundred.

Sender reputation is scored per mailbox and per sending domain. One inbox pushing a hundred cold emails a day looks like exactly what it is, and the penalty lands on the domain, which means it lands on your client correspondence too.

If the math says you need more volume, the answer is more mailboxes on more warmed sending domains, separate from the domain you invoice from. It is never more volume per mailbox. Ten to fifteen accounts a week at three touches is six to nine emails a day, one warmed mailbox with room to spare. This niche is about being early and specific, not about volume.

4.Write ten versions of every step and test them.

Versions A through J, not A and B. Rotate subject lines and bodies. You learn which angle is actually working instead of guessing, and there is a second reason that matters more: identical bodies going out over and over is one of the patterns postmaster tools flag. Variation is a deliverability tool as much as a testing one.

Subject line seeds for this niche, each of which should become several variants: "the date in your announcement", "the autoclave observation", "the contamination control strategy". Lower case, no punctuation tricks, and nothing that would look odd in a reply from a colleague.

5.Stop at three.

Most replies arrive on the first and second email. The third is already thin. Every touch past that raises the odds the whole thread gets classified as spam, and that classification follows the mailbox to the next person you write to. The long cadence is over. Three touches, each with something new in it, then leave them alone for ninety days.

6.Know what good looks like.

A one percent reply rate with a quarter of those replies positive is a healthy trigger based program. Anyone quoting you double digit reply rates is counting out of office messages or selling a course.

7.LinkedIn Sales Navigator is not optional.

Every other data source tells you who held a title at some point. Sales Navigator tells you who holds it today, because the person maintains it themselves. That is the difference between a three percent bounce rate and a fifteen percent one, and bounces are scored against the mailbox the same way spam complaints are. Verify the name there before anything goes out.

It is also the cheapest trigger detector you will own. The job change filter surfaces people who arrived in a role in the last ninety days, which is the moment they have budget and no incumbent. The posted recently filter surfaces companies talking about the exact problem you solve. Account lists with headcount growth alerts tell you who is scaling before the press release does. For this niche the saved search is headcount 50 to 1,000 in biotechnology, pharmaceutical manufacturing, cell and gene therapy, medical devices and contract manufacturing, titles VP Operations, VP Manufacturing, Head of Quality, Project Director and Facilities Director, with the job change alert on for those titles and a keyword alert on validation engineer, CQV and facilities manager across job listings. Navigator confirms the person. The announcements, permits, incentive awards and inspection databases are the source.

Use it for the research and the verification, not for the message. InMail reply rates are a fraction of email, and the person who replies to a thoughtful email is the same person who ignores a connection request with a pitch attached. Pull the work email from a data provider once Navigator has confirmed the person is real and current.

None of this is specific to your niche. All of it is specific to whether anyone ever reads the angle you spent an hour getting right.

If you would rather not run it yourself

That is what we do. ExpertLayer runs this exact loop for expert led firms: the weekly announcement, permit and funding pull, the qualification with the lifecycle question first, the angle per account naming the decision, the sending across warmed mailboxes, and the reply reading. You take the conversations and qualify the facility.

The first step is free and it is the same research described above. Send us your website and we will come back with 10 companies that hit these triggers right now, with the announcement or finding, the contact, and the opening line for each.

Questions from people running this

The engineering and construction firms already have the client. How do I get in?+

By writing to the owner about the handoff. The engineering firm delivers a commissioned building. The owner needs a qualified facility. The gap between those two is where schedules die, and the engineering firm does not own it. A note to the head of manufacturing that names that gap, before the building is finished, is a note nobody else is sending.

Inspection findings are public but delayed. Are they still useful?+

Very. A finding that cites equipment qualification or facility controls tells you the company's quality system has a specific hole, and the response commitment they made to the agency has a date. The delay means you are writing after the panic, when they are staffing the fix, which is when a contract validation team gets hired.

Cell and gene therapy or traditional biologics?+

Cell and gene therapy for a boutique, because the companies are smaller, the facilities are new, the timelines are compressed by clinical progress, and almost none of them have a validation function when they start building. Traditional biologics and large CDMOs have qualification groups and procurement. Lead with the former and the latter follows through referrals.

How early is too early to write?+

There is no too early once the facility is announced. The right time to plan qualification is during design, and the owner who hears that from you at the groundbreaking has you on the schedule. The company that hears it at mechanical completion has a schedule problem and is calling everyone.

Related

Start with 10 free targets.

Send us your website and the kind of customers you want. We come back with 10 bullseye prospects, why each one is relevant, and the outreach angle we would use. No charge, no obligation.

See how the review works